BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29197846)

  • 1. Severe recurrent hypothermia in an elderly patient with refractory mania associated with atypical antipsychotic, valproic acid and oxcarbazepine therapy.
    Ajayi OO; Holroyd S
    BMJ Case Rep; 2017 Dec; 2017():. PubMed ID: 29197846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
    Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M
    Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haloperidol alone or in combination for acute mania.
    Cipriani A; Rendell JM; Geddes JR
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004362. PubMed ID: 16856043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse.
    Maina G; Albert U; Salvi V; Mancini M; Bogetto F
    J Affect Disord; 2007 Apr; 99(1-3):247-51. PubMed ID: 17056122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between valproic acid and quetiapine/olanzapine in the treatment of bipolar disorder and the role of therapeutic drug monitoring.
    Vella T; Mifsud J
    J Pharm Pharmacol; 2014 Jun; 66(6):747-59. PubMed ID: 24392714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive treatment of acute mania: a clinical overview.
    Sachs GS; Gardner-Schuster EE
    Acta Psychiatr Scand Suppl; 2007; (434):27-34. PubMed ID: 17688460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DRESS syndrome: Addressing the drug hypersensitivity syndrome on combination of Sodium Valproate and Olanzapine.
    Penchilaiya V; Kuppili PP; Preeti K; Bharadwaj B
    Asian J Psychiatr; 2017 Aug; 28():175-176. PubMed ID: 28784381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxcarbazepine for acute affective episodes in bipolar disorder.
    Vasudev A; Macritchie K; Vasudev K; Watson S; Geddes J; Young AH
    Cochrane Database Syst Rev; 2011 Dec; (12):CD004857. PubMed ID: 22161387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective analysis of changing from alternative agents to carbamazepine extended-release capsules in bipolar disorder.
    Ginsberg LD
    Ann Clin Psychiatry; 2006; 18 Suppl 1():31-4. PubMed ID: 16754411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data.
    Suppes T; Brown E; Schuh LM; Baker RW; Tohen M
    J Affect Disord; 2005 Dec; 89(1-3):69-77. PubMed ID: 16253344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term use of atypical antipsychotics in bipolar disorder.
    Ehret MJ; Levin GM
    Pharmacotherapy; 2006 Aug; 26(8):1134-47. PubMed ID: 16863489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance treatment with quetiapine when combined with either lithium or divalproex in bipolar I disorder: analysis of two large randomized, placebo-controlled trials.
    Suppes T; Vieta E; Gustafsson U; Ekholm B
    Depress Anxiety; 2013 Nov; 30(11):1089-98. PubMed ID: 23761037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of bipolar depression: making sensible decisions.
    Citrome L
    CNS Spectr; 2014 Dec; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study.
    Tohen M; Ketter TA; Zarate CA; Suppes T; Frye M; Altshuler L; Zajecka J; Schuh LM; Risser RC; Brown E; Baker RW
    Am J Psychiatry; 2003 Jul; 160(7):1263-71. PubMed ID: 12832240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic drugs, mood stabilizers, and risk of pneumonia in bipolar disorder: a nationwide case-control study.
    Yang SY; Liao YT; Liu HC; Chen WJ; Chen CC; Kuo CJ
    J Clin Psychiatry; 2013 Jan; 74(1):e79-86. PubMed ID: 23419234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder.
    Ketter TA
    J Clin Psychiatry; 2008; 69 Suppl 5():9-15. PubMed ID: 19265635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age and adverse drug reactions from psychopharmacological treatment: data from the AMSP drug surveillance programme in Switzerland.
    Greil W; Häberle A; Schuhmann T; Grohmann R; Baumann P
    Swiss Med Wkly; 2013; 143():w13772. PubMed ID: 23821346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.